Approval · Notice of Compliance 26393 · 2021
IBUPROFEN CAPLETS: Notice of Compliance 26393
Issued August 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26393
- Date
- August 10, 2021
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Additional of private label brand mock-ups.
- Canadian reference product
- ADVIL IBUPROFEN CAPLETS, ADVIL EXTRA STRENGTH CAPLETS, ADVIL IBUPROFEN CAPLETS (Wyeth Consumer Healthcare Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | 02368080 | Marketed |
| IBUPROFEN EXTRA STRENGTH CAPLETS | 02368099 | Marketed |
| IBUPROFEN TABLETS | 02368072 | Dormant |